The quantitative presence of estrogen receptors (ERs) in breast cancer cells is indicative of their ER positive or ER negative classification.4 Much of the therapy surrounding breast cancer depends on the existence of ERs on the malignant cells. This evidence concerns the gene ESR1 and breast cancer.